© 2022 MJH Life Sciences and Dermatology Times and Multimedia Medical, LLC. All rights reserved.
© 2022 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.
Expert panelists provide an overview of diagnosing and treating plaque psoriasis, addressing specific challenges in patient management.
December 16th 2021
A panel of experts review the nature of plaque psoriasis and the mechanism of action of several classes of targeted therapy.
Shared insight on identifying clinical manifestations of plaque psoriasis and making a timely diagnosis.
December 23rd 2021
Panelists look deeper into the possible challenges or barriers to making an accurate diagnosis of plaque psoriasis
Considerations for the psychological and social impact that plaque psoriasis may have on a patient.
January 5th 2022
Centering discussion on a case of plaque psoriasis, experts share their experience with patient counseling and selecting therapy.
The panel reviews therapeutic classes and their respective benefits in patients being treated for plaque psoriasis.
January 10th 2022
Taking a broader look at moderate to severe plaque psoriasis, experts consider what the standard of care would be in different settings.
A brief review of biologic agents being used or evaluated in the setting of plaque psoriasis.
January 17th 2022
A focused discussion on the benefit of bimekizumab, an IL-17A/IL-17F inhibitor, in the setting of moderate to severe plaque psoriasis.
A panel of experts reflect on the toxicity profiles of biologic agents used to treat patients with plaque psoriasis.